1. Rochman, Mark, Malicet, Cedric, Bustin, Michael. . HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function. In Biochimica et biophysica acta, 1799, 86-92. doi:10.1016/j.bbagrm.2009.09.012. https://pubmed.ncbi.nlm.nih.gov/20123071/
2. Yao, Kun, He, Leye, Gan, Yu, Long, Zhi, Tan, Jing. 2020. HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27. In Aging, 12, 7282-7298. doi:10.18632/aging.103076. https://pubmed.ncbi.nlm.nih.gov/32315283/
3. Ma, Quanfeng, Wang, Xiuyu, Wang, Hong, Wang, Qiong, Wang, Jinhuan. 2020. HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells. In BioMed research international, 2020, 8610271. doi:10.1155/2020/8610271. https://pubmed.ncbi.nlm.nih.gov/32596388/
4. Su, Boxing, Shi, Bentao, Tang, Yuan, Gao, Xianshu, Zhou, Liqun. 2014. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation. In The Prostate, 75, 33-44. doi:10.1002/pros.22888. https://pubmed.ncbi.nlm.nih.gov/25307178/
5. Malicet, Cedric, Rochman, Mark, Postnikov, Yuri, Bustin, Michael. 2011. Distinct properties of human HMGN5 reveal a rapidly evolving but functionally conserved nucleosome binding protein. In Molecular and cellular biology, 31, 2742-55. doi:10.1128/MCB.05216-11. https://pubmed.ncbi.nlm.nih.gov/21518955/
6. Yang, Chaoqun, Gao, Rui, Wang, Jirong, Wang, Ce, Zhou, Xuhui. 2014. High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35, 6357-63. doi:10.1007/s13277-014-1833-0. https://pubmed.ncbi.nlm.nih.gov/24664583/
智鼠故事 
